Our results of upregulated TK1, TYMS and DTYMK in HCC tumors at RNA and protein levels in multiple independent HCC cohorts further suggested that pyrimidine metabolism especially dTTP biosynthesis pathway is upregulated in poorly-differentiated HCC cells to sustain cancer stemness resulted in poor survival of HCC patients. The gene discussed is DTYMK; the disease is cancer.